Short Courses

Monday, October 22

MORNING | 10:00 AM - 1:00 PM

SC1: Mechanism of Action and Risk-Based Approach for Developing Neutralizing Ab Assays - Detailed Agenda

Instructors: Jim McNally, PhD, Senior Director, Therapeutic Area Lead, Non-Clinical Development, Shire

AFTERNOON | 2:30 - 5:30 PM

SC2: Overcoming Drug Target Interference in ADA Assays - Detailed Agenda

Instructors: Jim McNally, PhD, Senior Director, Therapeutic Area Lead, Non-Clinical Development, Shire

Lilia Macovei, PhD, Senior Scientist, BioMedicine Design, Pfizer, Inc.

DINNER SHORT COURSES | 6:15 - 9:15 PM

SC3: Validation of ADA Assays and Cut Point Calculations - Detailed Agenda

Instructors: Jim McNally, PhD, Senior Director, Therapeutic Area Lead, Non-Clinical Development, Shire

Michael Partridge, PhD, Senior Staff Scientist, Bioanalytical Sciences, Regeneron Pharmaceuticals, Inc.

SC4: Immunology for Immuno-Oncology - Detailed Agenda

Part One: Harnessing the Body’s Natural Immune Response to Fight Cancer

Instructor: Jochem Gokemeijer, PhD, Associate Director, Molecular Discovery Technology, Bristol-Myers Squibb

Part Two: Adoptive T Cell Therapy

Instructor:J. Joseph (Jos) Melenhorst, PhD, Director, Product Development & Correlative Sciences, Cellular Immunotherapies, University of Pennsylvania

Wednesday, October 24

DINNER SHORT COURSES | 6:15 - 9:15 PM

SC5: Back to Basics: Optimizing Bioassay Design and Analysis - Detailed Agenda

Instructors: Sofie Pattijn, CTO, ImmunXperts

Annemie Wielant, Senior Scientist, Bioassay Development, UCB

Sylvia Janetzki, MD, President, ZellNet Consulting

SC6: Advice on Putting Together an Integrated Summary of Immunogenicity - Detailed Agenda

Instructors: Joao Pedras-Vasconcelos, PhD, Biotech Quality and Immunogenicity Reviewer, Office of Biotechnology Products, CDER, FDA

Bonnie Rup, PhD, Bonnie Rup Consulting LLC

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag